Inventor profile of:

Matthew C. Coffey

City:

Calgary

Country:

Canada

Published Applications:

69

Last publication date:

2020-07-30

Top Assignees for applications by Matthew C. Coffey

The entities that hold a legal rights for patent applications filed by inventor Coffey Matthew C.:

Recent patent applications by Coffey Matthew C.

Matthew C. Coffey from Calgary, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-07-30
US20200237917A1
Human necessities

Reoviruses having modified sequences

#2 | 2018-12-06
US20180344853A1
Human necessities

Reoviruses having modified sequences

#3 | 2016-09-22
US20160271193A1
Human necessities

ONCOLYTIC VIRUSES AND INCREASED CANCER TREATMENT REGIMENS

#4 | 2015-08-13
US20150224198A1
Human necessities

Lyophilized viral formulations

#5 | 2015-08-13
US20150224155A1
Human necessities

Liquid viral formulations

#6 | 2014-07-03
US20140186301A1
Chemistry; metallurgy

Reoviruses having modified sequences

#7 | 2014-06-26
US20140178969A1
Chemistry; metallurgy

Viral purification methods

#8 | 2013-10-17
US20130273012A1
Chemistry; metallurgy

Virus clearance of neoplastic cells from mixed cellular compositions

#9 | 2013-09-19
US20130243732A1
Human necessities

ABROGATING PROINFLAMMATORY CYTOKINE PRODUCTION DURING ONCOLYTIC REOVIRUS THERAPY

#10 | 2013-01-24
US20130022964A1
Chemistry; metallurgy

Use of ribozymes in the detection of adventitious agents

#11 | 2013-01-17
US20130017172A1
Human necessities

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#12 | 2012-11-01
US20120273424A1
Performing operations; transporting

METHODS OF PURIFYING VIRUSES USING GEL PERMEATION CHROMATOGRAPHY

#13 | 2012-09-06
US20120225045A1
Chemistry; metallurgy

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#14 | 2012-06-21
US20120156168A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#15 | 2012-06-07
US20120141528A1
Human necessities

Lyophilized viral formulations

#16 | 2012-06-07
US20120141426A1
Human necessities

Reovirus for the treatment of cellular proliferative disorders

#17 | 2012-06-07
US20120141421A1
Human necessities

Liquid viral formulations

#18 | 2011-10-06
US20110243890A1
Human necessities

Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus

#19 | 2011-08-18
US20110200565A1
Chemistry; metallurgy

Virus clearance of neoplastic cells from mixed cellular compositions

#20 | 2011-04-14
US20110086005A1
Human necessities

MODULATING INTERSTITIAL PRESSURE AND ONCOLYTIC VIRAL DELIVERY AND DISTRIBUTION

#21 | 2011-03-24
US20110070200A1
Human necessities

Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

#22 | 2011-01-27
US20110020288A1
Human necessities

Reoviruses having modified sequences

#23 | 2011-01-20
US20110014155A1
Human necessities

Reovirus for the treatment of cellular proliferative disorders

#24 | 2010-09-30
US20100248205A1
Chemistry; metallurgy

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#25 | 2010-09-30
US20100247622A1
Human necessities

TREATMENT REGIME FOR PROLIFERATIVE DISORDERS

#26 | 2010-08-12
US20100203147A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#27 | 2010-06-10
US20100143892A1
Chemistry; metallurgy

Use of ribozymes in the detection of adventitious agents

#28 | 2010-04-29
US20100105122A1
Physics

Oncolytic viruses as phenotyping agents for neoplasms

#29 | 2010-01-28
US20100021432A1
Human necessities

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#30 | 2009-05-07
US20090117082A1
Human necessities

Reovirus for the treatment of cellular proliferative disorders

#31 | 2009-04-30
US20090110665A1
Chemistry; metallurgy

REOVIRUS FOR THE TREATMENT OF NEOPLASIA

#32 | 2009-04-16
US20090098089A1
Chemistry; metallurgy

REOVIRUS FOR THE TREATMENT OF NEOPLASIA

#33 | 2009-02-05
US20090035278A2
Human necessities

REOVIRUSES HAVING MODIFIED SEQUENCES

#34 | 2008-11-27
US20080292594A1
Chemistry; metallurgy

MUTANT REOVIRUSES AND METHODS OF MAKING AND USING

#35 | 2008-09-18
US20080226602A1
Human necessities

Reoviruses having modified sequences

#36 | 2008-05-08
US20080108052A1
Chemistry; metallurgy

Use of Ribozymes in the Detection of Adventitious Agents

#37 | 2008-04-03
US20080081032A1
Human necessities

Method for reducing pain using oncolytic viruses

#38 | 2008-03-27
US20080075729A1
Human necessities

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

#39 | 2008-03-06
US20080057073A1
Physics

Methods for the treatment of cellular proliferative disorders

#40 | 2008-02-14
US20080038822A1
Chemistry; metallurgy

Virus clearance of neoplastic cells from mixed cellular compositions

#41 | 2008-02-07
US20080032279A1
Chemistry; metallurgy

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#42 | 2008-02-07
US20080031886A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#43 | 2008-02-07
US20080031851A1
Human necessities

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#44 | 2008-01-31
US20080026048A1
Human necessities

Reovirus for the treatment of cellular proliferative disorders

#45 | 2008-01-24
US20080019981A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#46 | 2008-01-24
US20080019980A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#47 | 2008-01-17
US20080014577A1
Physics

Oncolytic viruses as phenotyping agents for neoplasms

#48 | 2007-12-11
US10602024
-

Oncolytic viruses as phenotyping agents for neoplasms

#49 | 2007-11-27
US10403528
-

Reovirus for the treatment of neoplasia

#50 | 2007-11-22
US20070269856A1
Chemistry; metallurgy

Viral purification methods

#51 | 2007-09-04
US10076074
-

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#52 | 2007-08-07
US10418290
-

Viruses for the treatment of cellular proliferative disorders

#53 | 2007-05-29
US10424985
-

Viral purification methods

#54 | 2007-04-19
US20070086984A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#55 | 2007-04-03
US10431579
-

Sensitization of neoplastic cells to radiation therapy with reovirus

#56 | 2006-08-03
US20060172288A1
Physics

Methods for the treatment of cellular proliferative disorders

#57 | 2006-07-27
US20060165724A1
Human necessities

Method of producing infectious reovirus

#58 | 2006-05-30
US9985756
-

Methods for the treatment of cellular proliferative disorders

#59 | 2006-05-23
US10734552
-

Method of producing infectious reovirus

#60 | 2006-04-27
US20060088869A1
Chemistry; metallurgy

Viral purification methods

#61 | 2006-04-06
US20060073166A1
Human necessities

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

#62 | 2006-03-21
US10401032
-

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

#63 | 2006-02-09
US20060029598A1
Chemistry; metallurgy

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#64 | 2006-02-07
US9847356
-

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#65 | 2005-09-29
US20050214266A1
Human necessities

Combination of transplantation and oncolytic virus treatment

#66 | 2005-06-09
US20050123513A1
Chemistry; metallurgy

Reovirus for the treatment of neoplasia

#67 | 2005-05-05
US20050095692A1
Chemistry; metallurgy

Method of extracting virus from cell culture

#68 | 2005-03-24
US20050063954A1
Human necessities

Reovirus for the treatment of cellular proliferative disorders

#69 | 2005-02-03
US20050026289A1
Chemistry; metallurgy

Virus clearance of neoplastic cells from mixed cellular compositions

InventorID:

40104 ⎘